UniQure's Huntington's gene therapy trial data disappoints
UNIQUREHUNTINGTON
Statements (2)
- Bearish
UniQure stock price falls following disappointing trial data from Huntington's
- Neutral
UniQure insists Huntington's drug is still on track
UniQure stock price falls following disappointing trial data from Huntington's
UniQure insists Huntington's drug is still on track